FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036485264> ?p ?o ?g. }

• W3036485264 endingPage "681" @default.
• W3036485264 startingPage "675" @default.
• W3036485264 abstract "Background and Aim: The clinical utility of sorafenib plus hepatic arterial infusion chemotherapy (SoraHAIC) in advanced hepatocellular carcinoma (HCC) patients remains unclear. We, therefore, conducted the current meta-analysis to systematically evaluate the efficacy and safety of SoraHAIC therapy on major outcomes with advanced HCC patients. Methods: A systematic search of The Cochrane Library, PubMed, and Embase databases was performed. The major outcomes in patients with advanced HCC were divided into SoraHAIC group and sorafenib group, which included overall response rate, overall survival, progressive disease, and adverse events. Results: Involving a total of 726 patients from 5 included studies, our meta-analysis demonstrated that SoraHAIC showed significantly more improvement than sorafenib alone in overall response rate [risk ratio=3.08; 95% confidence interval (CI), 1.38-6.89; P =0.006] and complete response (risk ratio=5.84; 95% CI, 1.85-18.45; P =0.003). With regard to survival outcome, the combination therapy also significantly prolongs the median overall survival than sorafenib monotherapy (hazard ratio=0.59; 95% CI, 0.35-1.00; P =0.05). In addition, the risk of adverse events such as anemia, neutropenia, and thrombocytopenia was significantly greater in the combination group than in the sorafenib group ( P <0.05 for all). Conclusions: This meta-analysis indicated that SoraHAIC seems to be efficient and safe for advanced HCC patients. However, additional large-scale randomized controlled trials are needed to further investigate the clinical benefit." @default.
• W3036485264 created "2020-06-25" @default.
• W3036485264 creator A5015439039 @default.
• W3036485264 creator A5031991387 @default.
• W3036485264 creator A5046394520 @default.
• W3036485264 creator A5058479146 @default.
• W3036485264 creator A5069340040 @default.
• W3036485264 creator A5070169946 @default.
• W3036485264 creator A5080134626 @default.
• W3036485264 creator A5084796212 @default.
• W3036485264 date "2020-06-19" @default.
• W3036485264 modified "2023-10-18" @default.
• W3036485264 title "Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma" @default.
• W3036485264 cites W1176097286 @default.
• W3036485264 cites W1594651356 @default.
• W3036485264 cites W1757407923 @default.
• W3036485264 cites W1971837077 @default.
• W3036485264 cites W1988475963 @default.
• W3036485264 cites W1994193851 @default.
• W3036485264 cites W1996869264 @default.
• W3036485264 cites W2016018273 @default.
• W3036485264 cites W2020362401 @default.
• W3036485264 cites W2024450952 @default.
• W3036485264 cites W2024802373 @default.
• W3036485264 cites W2032084645 @default.
• W3036485264 cites W2044641518 @default.
• W3036485264 cites W2058887247 @default.
• W3036485264 cites W2060779897 @default.
• W3036485264 cites W2085498353 @default.
• W3036485264 cites W2092634991 @default.
• W3036485264 cites W2137052325 @default.
• W3036485264 cites W2162732991 @default.
• W3036485264 cites W2238432908 @default.
• W3036485264 cites W2394755937 @default.
• W3036485264 cites W2468996569 @default.
• W3036485264 cites W2512061943 @default.
• W3036485264 cites W2554080066 @default.
• W3036485264 cites W2558253459 @default.
• W3036485264 cites W2773914067 @default.
• W3036485264 cites W2795708663 @default.
• W3036485264 cites W2944033593 @default.
• W3036485264 cites W2981257152 @default.
• W3036485264 cites W43271413 @default.
• W3036485264 doi "https://doi.org/10.1097/mcg.0000000000001384" @default.
• W3036485264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32569032" @default.
• W3036485264 hasPublicationYear "2020" @default.
• W3036485264 type Work @default.
• W3036485264 sameAs 3036485264 @default.
• W3036485264 citedByCount "9" @default.
• W3036485264 countsByYear W30364852642021 @default.
• W3036485264 countsByYear W30364852642022 @default.
• W3036485264 countsByYear W30364852642023 @default.
• W3036485264 crossrefType "journal-article" @default.
• W3036485264 hasAuthorship W3036485264A5015439039 @default.
• W3036485264 hasAuthorship W3036485264A5031991387 @default.
• W3036485264 hasAuthorship W3036485264A5046394520 @default.
• W3036485264 hasAuthorship W3036485264A5058479146 @default.
• W3036485264 hasAuthorship W3036485264A5069340040 @default.
• W3036485264 hasAuthorship W3036485264A5070169946 @default.
• W3036485264 hasAuthorship W3036485264A5080134626 @default.
• W3036485264 hasAuthorship W3036485264A5084796212 @default.
• W3036485264 hasConcept C126322002 @default.
• W3036485264 hasConcept C141071460 @default.
• W3036485264 hasConcept C143998085 @default.
• W3036485264 hasConcept C168563851 @default.
• W3036485264 hasConcept C197934379 @default.
• W3036485264 hasConcept C207103383 @default.
• W3036485264 hasConcept C2776478404 @default.
• W3036485264 hasConcept C2776694085 @default.
• W3036485264 hasConcept C2777063308 @default.
• W3036485264 hasConcept C2778019345 @default.
• W3036485264 hasConcept C2778695046 @default.
• W3036485264 hasConcept C44249647 @default.
• W3036485264 hasConcept C71924100 @default.
• W3036485264 hasConcept C90924648 @default.
• W3036485264 hasConcept C95190672 @default.
• W3036485264 hasConceptScore W3036485264C126322002 @default.
• W3036485264 hasConceptScore W3036485264C141071460 @default.
• W3036485264 hasConceptScore W3036485264C143998085 @default.
• W3036485264 hasConceptScore W3036485264C168563851 @default.
• W3036485264 hasConceptScore W3036485264C197934379 @default.
• W3036485264 hasConceptScore W3036485264C207103383 @default.
• W3036485264 hasConceptScore W3036485264C2776478404 @default.
• W3036485264 hasConceptScore W3036485264C2776694085 @default.
• W3036485264 hasConceptScore W3036485264C2777063308 @default.
• W3036485264 hasConceptScore W3036485264C2778019345 @default.
• W3036485264 hasConceptScore W3036485264C2778695046 @default.
• W3036485264 hasConceptScore W3036485264C44249647 @default.
• W3036485264 hasConceptScore W3036485264C71924100 @default.
• W3036485264 hasConceptScore W3036485264C90924648 @default.
• W3036485264 hasConceptScore W3036485264C95190672 @default.
• W3036485264 hasIssue "8" @default.
• W3036485264 hasLocation W30364852641 @default.
• W3036485264 hasOpenAccess W3036485264 @default.
• W3036485264 hasPrimaryLocation W30364852641 @default.
• W3036485264 hasRelatedWork W1900595920 @default.
• W3036485264 hasRelatedWork W1990960836 @default.
• W3036485264 hasRelatedWork W2378315152 @default.

• next